Health A-Z
Find Services & Information
Multiple Sclerosis
Natalizumab (marketed as Tysabri) Information
On June 5, 2006, the Food and Drug Administration (FDA) approved an application for resumed marketing of Tysabri (natalizumab), a monoclonal antibody, for the treatment of patients with relapsing form... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Research on MS 
MS research is moving at a rapid pace. Many different avenues are being explored for treatment; many theories are being examined as to the cause and cure. Information on the progress of these studies ... Details >
Resources and Offerings for People with Multiple Sclerosis
This page provides a quick overview of the Accelerated Cure Project for Multiple Sclerosis and the resources offered at no charge to people with multiple sclerosis and those who care about them.... Details >
Support Groups - Multiple Sclerosis Association of America (MSAA)
This page offers a listing of Multiple Sclerosis Association of America (MSAA) support groups held in your state or geographic region. MSAA support groups provide safe environments where people, who h... Details >
Symptoms of MS
Common symptoms of MS include fatigue, weakness, spasticity, balance problems, bladder and bowel problems, numbness, vision loss, tremors and depression. ... Details >
Treatment for MS
Studies indicate that early treatment delays disability, presumably by decreasing the injury to the nervous system caused by the disease. ... Details >